BioCells2Cure is a research organization specialized in advanced breast cancer. Our research focuses on finding new ways to treat breast cancer metastasis in order to eliminate breast cancer as a deadly disease. We constantly work on improving our breast cancer models and discover potential predcitive biomarkers to help guide therapy selection.

BioCells2Cure uses clinically relevant cell-based models of advanced breast cancer to evaluate drug efficacy, identify predictive biomarkers, and help design clinical trials.  Better selection of compounds before entering the clinic and appropriate trial designs can help decrease the time and cost to bring to market novel strategies to treat advanced breast cancer.